These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 20331911)
1. Epistasis between APOE and nicotinic receptor gene CHRNA4 in age related cognitive function and decline. Reinvang I; Lundervold AJ; Wehling E; Rootwelt H; Espeseth T J Int Neuropsychol Soc; 2010 May; 16(3):424-32. PubMed ID: 20331911 [TBL] [Abstract][Full Text] [Related]
2. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270 [TBL] [Abstract][Full Text] [Related]
3. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Knopman DS; Mosley TH; Catellier DJ; Coker LH; Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884 [TBL] [Abstract][Full Text] [Related]
4. Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype. Bracco L; Piccini C; Baccini M; Bessi V; Biancucci F; Nacmias B; Bagnoli S; Sorbi S Dement Geriatr Cogn Disord; 2007; 24(6):483-91. PubMed ID: 18025782 [TBL] [Abstract][Full Text] [Related]
5. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. Portaccio E; Goretti B; Zipoli V; Nacmias B; Stromillo ML; Bartolozzi ML; Siracusa G; Guidi L; Federico A; Sorbi S; De Stefano N; Amato MP Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518 [TBL] [Abstract][Full Text] [Related]
6. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers. Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495 [TBL] [Abstract][Full Text] [Related]
7. The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology. Ramakers IH; Visser PJ; Aalten P; Bekers O; Sleegers K; van Broeckhoven CL; Jolles J; Verhey FR Dement Geriatr Cogn Disord; 2008; 26(2):101-8. PubMed ID: 18617739 [TBL] [Abstract][Full Text] [Related]
8. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment. Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169 [TBL] [Abstract][Full Text] [Related]
9. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset. van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933 [TBL] [Abstract][Full Text] [Related]
10. Homocysteine and cognitive performance: modification by the ApoE genotype. Elias MF; Robbins MA; Budge MM; Elias PK; Dore GA; Brennan SL; Johnston C; Nagy Z Neurosci Lett; 2008 Jan; 430(1):64-9. PubMed ID: 18023533 [TBL] [Abstract][Full Text] [Related]
11. Systemic markers of inflammation and cognitive decline in old age. Schram MT; Euser SM; de Craen AJ; Witteman JC; Frölich M; Hofman A; Jolles J; Breteler MM; Westendorp RG J Am Geriatr Soc; 2007 May; 55(5):708-16. PubMed ID: 17493190 [TBL] [Abstract][Full Text] [Related]
12. APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis. Shi J; Tu JL; Gale SD; Baxter L; Vollmer TL; Campagnolo DI; Tyry TM; Zhuang Y; Kuniyoshi SM Cogn Behav Neurol; 2011 Sep; 24(3):128-33. PubMed ID: 21945984 [TBL] [Abstract][Full Text] [Related]
13. Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele. O'Hara R; Sommer B; Way N; Kraemer HC; Taylor J; Murphy G J Psychiatr Res; 2008 Feb; 42(3):199-204. PubMed ID: 17250852 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults. Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298 [TBL] [Abstract][Full Text] [Related]
15. Impact of APOE status on cognitive maintenance in healthy elderly persons. Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E and cognitive performance: a meta-analysis. Small BJ; Rosnick CB; Fratiglioni L; Bäckman L Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785 [TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment in Alzheimer's disease is modified by APOE genotype. van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691 [TBL] [Abstract][Full Text] [Related]
18. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347 [TBL] [Abstract][Full Text] [Related]
19. Association between ApoE epsilon4 and cognitive impairment after stroke. Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491 [TBL] [Abstract][Full Text] [Related]
20. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age. van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]